TickerFacts.

Company research / ALHC

Alignment Healthcare, Inc. (ALHC)

Build a valuation ↗↓ Download CSV

CIK 0001832466 · Nasdaq · Hospital & Medical Service Plans

  • Sector Finance & Real Estate
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Alignment Healthcare, Inc. reported revenue of $3.95B. Revenue grew 46.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $4.58B.

Key ratios (year ended 2025-12-31)

0.4%
Operating margin
0.0%
Net margin
-0.4%
Return on year-end equity
46.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$4.58B$3.95B$2.70B$1.82B$1.43B$1.17B$959.22M$756.96M
Operating Income$55.00M$14.75M-$101.56M-$127.82M-$128.64M-$178.07M-$5.26M-$29.48M
Depreciation & Amortization$31.50M$30.40M$26.87M$21.41M$17.27M$15.81M$15.10M$14.92M
EBITDA$86.50M$45.16M-$74.68M-$106.40M-$111.37M-$162.26M$9.83M-$14.56M
Net Income$40.70M-$724.0K-$128.03M-$148.02M-$149.55M-$195.29M-$22.93M-$44.73M
EPS (Diluted)n/a$0.00-$0.67-$0.79-$0.83-$1.14-$0.15n/a
Total Assets$1.28B$1.07B$782.06M$591.88M$633.86M$630.89M$338.50Mn/a
Total Liabilities$1.01B$886.51M$681.11M$433.81M$394.56M$324.84M$307.89Mn/a
Long-Term Debt$324.06M$323.18M$321.43M$161.81M$160.90M$150.62M$144.17Mn/a
Shareholders' Equity$265.13M$179.28M$100.95M$158.07M$239.30M$306.06M$30.61M-$78.71M
Cash & Equivalents$693.45M$575.82M$432.86M$202.90M$409.55M$466.60M$207.31M$86.48M
Operating Cash Flow$205.55M$139.93M$34.77M-$59.19M-$45.43M-$78.78M$7.56M$9.21M
Capital Expenditures$28.04M$26.78M$41.42M$35.99M$23.77Mn/an/an/a
Free Cash Flow$177.51M$113.15M-$6.65M-$95.18M-$69.20Mn/an/an/a
Shares Outstanding207.18M204.15M191.78M188.95M187.28M187.19M164.06Mn/a
Weighted Average Diluted Sharesn/a198.01M190.79M186.21M181.21M181.92Mn/an/a
EPS (Basic)n/a$0.00-$0.67-$0.79-$0.83-$1.14-$0.15n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView